Adjuvant Clinical Trials in Shanghai, Shanghai Municipality
12 recruitingShanghai, Shanghai Municipality, China
Showing 1–12 of 12 trials
Recruiting
Not Applicable
Digital Mind-Body Therapy for Neoadjuvant Breast Cancer
Neoadjuvant Therapy
Fudan University66 enrolled1 locationNCT07541664
Recruiting
Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC
Lung CancerNeoadjuvant Therapy
Shanghai Chest Hospital400 enrolled1 locationNCT07135856
Recruiting
Phase 2
Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
Neoadjuvant TherapyEsophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital26 enrolled1 locationNCT07266493
Recruiting
Phase 2
Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)
Neoadjuvant TherapyLocally Advanced Rectal Cancer
Fudan University138 enrolled1 locationNCT07150949
Recruiting
Phase 3
Neoadjuvant SNF Precision Therapy Phase III
Neoadjuvant Therapy
Fudan University404 enrolled1 locationNCT06913777
Recruiting
Phase 3
A Phase III, Active-Controlled Study of SHR-A1811 Versus Trastuzumab Emtansine (T-DM1) in HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy
HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy
Jiangsu HengRui Medicine Co., Ltd.1,600 enrolled2 locationsNCT06126640
Recruiting
Safety and Efficacy of IMPT or IMRT for Breast Cancer
Breast CancerProton TherapyIntensity Modulated Radiation Therapy+2 more
Ruijin Hospital500 enrolled1 locationNCT06826885
Recruiting
Not Applicable
Neoadjuvant Radiotherapy for Breast Cancer
Breast CancerNeoadjuvant Radiotherapy
Changhai Hospital60 enrolled1 locationNCT06313073
Recruiting
Phase 1Phase 2
Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy
Neoadjuvant TreatmentRectal CancerRadiotherapy+1 more
Shanghai Minimally Invasive Surgery Center20 enrolled1 locationNCT05111860
Recruiting
Phase 2
Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery
Cervical CancerNeoadjuvant ImmunotherapyFertility-sparing Surgery
Xiaohua Wu30 enrolled1 locationNCT06209294
Recruiting
Phase 2
Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma
Esophageal Squamous Cell CarcinomaAdjuvant TherapyNeoadjuvant Chemoimmunotherapy
Guo Xufeng73 enrolled1 locationNCT06056336
Recruiting
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell CarcinomaNeoadjuvant Chemoimmunotherapy
Shanghai Zhongshan Hospital40 enrolled1 locationNCT05740995